aTyr Pharma
ATYR • NASDAQ
aTyr Pharma is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sanjay S. Shukla, with a market cap of $73.5M.
Market Cap$73.5M
Employees59.0
CEOSanjay S. Shukla
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 6, 2026 · In 3 weeksQ1 2026
Financials
ATY
aTyr Pharma FAQ
Common questions about aTyr Pharma
aTyr Pharma is scheduled to report earnings for Q1 2026 on May 6, 2026. Analysts estimate revenue of $20.0K.
aTyr Pharma has approximately 59 employees.